Privium Fund Management (UK)’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-7,314
Closed -$78.2K 91
2023
Q2
$78.2K Hold
7,314
0.06% 66
2023
Q1
$85.1K Sell
7,314
-14,628
-67% -$204K 0.07% 60
2022
Q4
$188K Buy
21,942
+12,809
+140% +$113K 0.14% 44
2022
Q3
$70K Buy
+9,133
New +$101K 0.09% 53

Other funds holding TECX

Privium Fund Management (UK)'s TECX Position: Q3 2023 in Review

Privium Fund Management (UK) sold out of Tectonic Therapeutic (TECX) in Q3 2023, closing a stake of 7,314 shares — an estimated $78.2K sold.

Privium Fund Management (UK) first reported a position in TECX in Q3 2022 and held it in 4 quarters. The position peaked at $188K in Q4 2022. 47 funds tracked by Wall St. Rank hold TECX as of Q3 2023.

  • Privium Fund Management (UK) reported no remaining Tectonic Therapeutic position as of Q3 2023 after selling out during the quarter.
  • Privium Fund Management (UK) sold 7,314 Tectonic Therapeutic shares in Q3 2023, an estimated $78.2K.
  • Privium Fund Management (UK) first reported a position in Tectonic Therapeutic in Q3 2022 and held it in 4 quarters.
  • Privium Fund Management (UK)'s Tectonic Therapeutic position peaked at $188K in Q4 2022.
  • 47 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2023.

Based on Privium Fund Management (UK)'s 13F filing for Q3 2023, filed 6 Nov 2023.